HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

oxalyl bis(N-phenyl)hydroxamic acid

structure in first source

Also Known As:

OBP, hydroxamic acid; OBPHA compound

Networked: 2 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Banerjee, Kaushik: 1 article (10/2021)
2.	Choudhuri, Soumitra Kumar: 1 article (10/2021)
3.	Bhattacharya, S: 1 article (11/2006)
4.	Choudhuri, S K: 1 article (11/2006)
5.	Datta, E R: 1 article (11/2006)
6.	Dutta, P: 1 article (11/2006)
7.	Efferth, T: 1 article (11/2006)
8.	Majumder, S: 1 article (11/2006)
9.	Mukherjee, P: 1 article (11/2006)

Related Diseases

1.	Neoplasms (Cancer) 10/01/2021 - "Since oxalyl-bis(N-phenyl)hydroxamic acid (OBPHA) exerts significant efficacy against cancer, we believe that derivatives of OBPHA including organotin molecule can show a promising effect against cancer. "
2.	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/28/2006 - "In the present investigation, we describe the effect of oxalyl bis (N-phenyl) hydroxamic acid (OBPHA) and copper N-(2-hydroxy acetophenone) glycinate (CuNG) on multidrug-resistant P-gp-expressing CEM/ADR5000 T-cell acute lymphoblastic leukemia cells. "
3.	Leukemia 11/28/2006 - "Reversal of drug resistance in P-glycoprotein-expressing T-cell acute lymphoblastic CEM leukemia cells by copper N-(2-hydroxy acetophenone) glycinate and oxalyl bis (N-phenyl) hydroxamic acid."

Related Drugs and Biologics

1.	Member 1 Subfamily B ATP Binding Cassette Transporter
2.	Copper